(Q21092367)

mild cognitive impairment

1 reference

1 reference

inferred from title

cognitive dysfunction

1 reference

3

Nicola Vanacore

Nicola

Vanacore

1 reference

15 August 2022

2

Emiliano Albanese

Emiliano

Albanese

1 reference

15 August 2022

Roberto Raschetti

1

Roberto

Raschetti

1 reference

18044984

15 August 2022

Marina Maggini

series ordinal

4

author given names

Marina

author last names

Maggini

1 reference

18044984

Creative Commons Attribution 4.0 International

15 August 2022

language of work or name

English

0 references

publication date

27 November 2007

4 references

25 April 2019

19 September 2019

2 October 2019

30 January 2021

4 references

25 April 2019

19 September 2019

2 October 2019

30 January 2021

4

0 references

issue

11

0 references

page(s)

e338

0 references

copyright license

4 references

25 April 2019

19 September 2019

2 October 2019

The fight against disease mongering: generating knowledge for action

30 January 2021

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Global prevalence of dementia: a Delphi consensus study

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Selling sickness: the pharmaceutical industry and disease mongering

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Donepezil for mild cognitive impairment

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Galantamine for Alzheimer's disease and mild cognitive impairment

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Alzheimer disease: progress or profit?

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Mild cognitive impairment: clinical characterization and outcome

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

A clinical approach to mild cognitive impairment

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Role of cholinesterase inhibitors in dementia care needs rethinking

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Clinical trials in mild cognitive impairment: lessons for the future

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Mild cognitive impairment as a clinical entity and treatment target

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Vitamin E and donepezil for the treatment of mild cognitive impairment

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Mild cognitive impairment clinical trials

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

National estimates of the quantity and cost of informal caregiving for the elderly with dementia

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

What makes clinical research ethical?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Regulatory authorities review use of galantamine in mild cognitive impairment

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Alzheimer's disease--clinical trials and the logic of clinical purpose.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Drug prescription in mild cognitive impairment: the physicians' perspective in Italy.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Risk factors for transitions from normal to mild cognitive impairment and dementia.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Mild cognitive impairment: to treat or not to treat

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Vascular risk factors, incidence of MCI, and rates of progression to dementia

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Incidence and outcome of mild cognitive impairment in a population-based prospective cohort

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Mild cognitive impairment: conceptual basis and current nosological status.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2082649

Cholinesterase inhibitors in mild cognitive impairment: a meta-analysis of randomized controlled trials

29 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/18044984

12 December 2020

Hepatotoxicity of tacrine: occurrence of membrane fluidity alterations without involvement of lipid peroxidation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18044984

12 December 2020

https://pubmed.ncbi.nlm.nih.gov/18044984

1 reference

12 December 2020

Mild cognitive impairment is not a clinical entity and should not be treated

1 reference

https://pubmed.ncbi.nlm.nih.gov/18044984

12 December 2020

Mild cognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18044984

12 December 2020

Mild cognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18044984

12 December 2020

Mild cognitive impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18044984

12 December 2020

10.1371/JOURNAL.PMED.0040338

Identifiers

DOI

1 reference

release_teq4a7ofozhxzhalj32fh3qfty

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/teq4a7ofozhxzhalj32fh3qfty

24 November 2022

mapped directly with Wikidata item

1 reference

1 reference

18044984

1 reference